MedPath

Bausch & Lomb Incorporated

🇺🇸United States
Ownership
-
Established
1992-10-08
Employees
-
Market Cap
-
Website

Product Performance of a Toric Contact Lens

Not Applicable
Completed
Conditions
Myopia
Astigmatism
Interventions
Device: SofLens DD Toric
Device: Ciba Vision Focus Dailies Toric Contact Lens
First Posted Date
2008-04-16
Last Posted Date
2011-12-12
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
220
Registration Number
NCT00658996
Locations
🇲🇾

Laser Focus Sdn Bhd, Vision Correction Centre, Johor Bahru, Malaysia

Performance of Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution in a New Packaging Configuration

Not Applicable
Completed
Conditions
Comfort
Interventions
Device: Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution Packaged in the Currently Marketed Resin Bottle.
Device: Bausch & Lomb ReNu MultiPlus Multi-Purpose Solution Packaged in a Clear Resin Bottle.
First Posted Date
2008-04-16
Last Posted Date
2011-12-12
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
312
Registration Number
NCT00659815
Locations
🇺🇸

James Ferrari, OD, Rochester, New York, United States

Loteprednol Etabonate Ophthalmic Ointment vs. Vehicle in the Treatment of Inflammation Following Cataract Surgery

Phase 3
Completed
Conditions
Ocular Inflammation
Interventions
Drug: 0.5% Loteprednol Etabonate Ophthalmic Ointment
First Posted Date
2008-03-28
Last Posted Date
2015-03-24
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
400
Registration Number
NCT00645671
Locations
🇺🇸

John Hunkeler, MD, Overland Park, Kansas, United States

Comparative Performance of PureVision, Acuvue Oasys and O2Optix

Phase 4
Completed
Conditions
Myopia
Interventions
Device: PureVision Contact Lens
Device: Acuvue Oasys Contact Lens
Device: O2Optix Contact lens
First Posted Date
2008-03-21
Last Posted Date
2011-12-12
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
510
Registration Number
NCT00640341
Locations
🇺🇸

Anderson & Associates, Tampa, Florida, United States

Safety and Efficacy of a Bausch & Lomb Multipurpose Solution When Compared to Ciba Vision Aquify Multipurpose Solution

Not Applicable
Completed
Conditions
Contact Lens Solutions
Interventions
Device: Bausch & Lomb Multipurpose Solution - No Rub Care
Device: Bausch & Lomb Multipurpose Solution - Rub Care
Device: Ciba Vision Aquify Multipurpose Solution
First Posted Date
2008-03-14
Last Posted Date
2015-03-24
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
541
Registration Number
NCT00636363
Locations
🇺🇸

Place Eye Care, LeRoy, New York, United States

Comparative Performance of a Bausch & Lomb Multipurpose Solution and Alcon OptiFree Replenish Multipurpose Solution

Not Applicable
Completed
Conditions
Adverse Effect of Contact Lens Solution
Interventions
Device: Bausch & Lomb Multipurpose Solution
Device: Alcon OptiFree Replenish Multipurpose Solution
First Posted Date
2008-03-14
Last Posted Date
2011-12-13
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
361
Registration Number
NCT00636194
Locations
🇲🇾

Laser Focus Sdn Bhd, Vision Correction Centre, Jalan Kuning, Tamn Pelangi, Johor Bahru, Malaysia

Clinical and Microbial Efficacy of ISV403 in Bacterial Conjunctivitis

Phase 2
Completed
Conditions
Bacterial Conjunctivitis
Interventions
Drug: Vehicle
First Posted Date
2008-02-25
Last Posted Date
2015-03-24
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
270
Registration Number
NCT00622908

A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension.

Phase 2
Completed
Conditions
Primary Open Angle Glaucoma
Ocular Hypertension
Interventions
First Posted Date
2008-01-16
Last Posted Date
2020-09-14
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
117
Registration Number
NCT00595101
Locations
🇯🇵

Pfizer Investigational Site, Shizuoka, Japan

Safety Study for Bepotastine Besilate Ophthalmic Solution in Normal Volunteers

Phase 3
Completed
Conditions
Allergic Conjunctivitis
Interventions
Drug: Placebo
First Posted Date
2008-01-04
Last Posted Date
2013-02-15
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
861
Registration Number
NCT00586625

Efficacy and Safety Study of Bepotastine Besilate Ophthalmic Solution in Allergic Conjunctivitis

Phase 3
Completed
Conditions
Allergic Conjunctivitis
Interventions
First Posted Date
2008-01-04
Last Posted Date
2013-02-08
Lead Sponsor
Bausch & Lomb Incorporated
Target Recruit Count
130
Registration Number
NCT00586664
Locations
🇺🇸

ISTA Pharmaceuticals, Inc., Irvine, California, United States

© Copyright 2025. All Rights Reserved by MedPath